Key result
Sporadic inclusion body myositis is associated with a ~56-month diagnostic delay and widespread psychological anxiety.
Why the study?
Sporadic inclusion body myositis is an intractable, progressive muscle disease of unknown etiology without effective treatment, and its cross-sectional profile in Japan needed elucidation.
Cross-Sectional (n=146)
Yes
Patients with sporadic inclusion body myositis in Japan experience significant diagnostic delays and high rates of psychological and financial anxiety.
Answers are grounded in this paper and cite their sources.
Diagnostic delays and burdens in sporadic inclusion body myositis merit clinical vigilance; leaves open optimal strategies for earlier recognition in rare myopathies.
BACKGROUND: Sporadic inclusion body myositis (sIBM) is the most prevalent acquired muscle disease in the elderly. sIBM is an intractable and progressive disease of unknown cause and without effective treatment. The etiology of sIBM is still unknown; however, genetic factors, aging, lifestyles, and environmental factors may be involved. The purpose of this study is to elucidate the cross-sectional profile of patients affected by sIBM in Japan. METHODS: We surveyed patient data for 146 cases diagnosed at a number of centers across Japan. We also issued a questionnaire for 67 patients and direct caregivers to further elucidate the natural history of the disease. RESULTS: The mean age at the onset was 63.4 ± 9.2 years. The mean length of time from the onset to diagnosis was 55.52 ± 49.72 months, suggesting that there is a difficulty in diagnosing this disease with long-term consequences because of late treatment. 73 % described the psychological/mental aspect of the disease. The most popular primary caregiver was the patient's spouse and 57 % patients mentioned that they were having problems managing the finances. CONCLUSIONS: Through these surveys, we described the cross-sectional profiles of sIBM in Japan. Many patients described psychological/mental and financial anxiety because of the aged profile of sIBM patients. The profiles of sIBM patients are similar to those in Western countries.
No takes yet. Share an insight, caveat, or question.
Suzuki et al. (2016) conducted a cross-sectional in Sporadic inclusion body myositis (sIBM) (n=146). Sporadic inclusion body myositis (sIBM) was evaluated on Cross-sectional clinical profile, diagnostic delay, and patient-reported anxiety. In a cross-sectional survey of Japanese patients with sporadic inclusion body myositis, the mean time from onset to diagnosis was 55.5 months, with 73% of patients reporting psychological anxiety.
Synapse has enriched 10 related papers. Consider them for comparative context: